Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
<h4>Introduction</h4>Although Sensititre Mycobacterium tuberculosis (MYCOTB) plate offers both drug susceptibility testing (DST) and minimum inhibitory concentration (MIC) results, it has not been evaluated against both Lowenstein Jensen (LJ) and Middlebrook 7H10 (MB7H10) DST methods at...
Saved in:
| Main Authors: | Willy Ssengooba, Germine Nakayita, Carolyn C Namaganda, Moses L Joloba |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199638&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug susceptibility testing of M. tuberculosis with the help of test system of Sensititre MycoTB TREK Diagnostics
by: M. V. Makarova, et al.
Published: (2015-04-01) -
Tumor de Buschke Lowenstein
by: Arnel Pupo Ricardo, et al.
Published: (2016-03-01) -
BUSCHKE-LOWENSTEIN TUMOR PREGNANCY (CLINICAL CASE)
by: Татьяна Владимировна Ананьева, et al.
Published: (2021-04-01) -
Diagnostic accuracy of point-of-care triage tests for pulmonary tuberculosis using host blood protein biomarkers: a systematic review and meta-analysisResearch in context
by: Kevin Komakech, et al.
Published: (2025-06-01) -
The Giant Condyloma (Buschke-Löwenstein Tumor) in the Immunocompromised Patient
by: Andrew L. Atkinson, et al.
Published: (2014-01-01)